11 Emerging Standards for PLA2R Antibody Testing Protocols in 2026 Refining the Role of PLA2R Antibody Testing
In 2026, the clinical utility of PLA2R antibody testing has expanded from a simple diagnostic marker to a sophisticated tool for dynamic monitoring of autoimmune kidney disease treatment. High-titer levels are now recognized as early predictors of relapse, allowing for preemptive adjustments in immunosuppressive kidney therapy before clinical...